SCHEMBL6522032

SCHEMBL6522032

[CH2]c1ccc(O)cc1CCC

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TYR P14679 3/20 0.46
ESR1 P03372 8/20 0.44
ESR2 Q92731 6/20 0.44
HSD17B3 P37058 1/20 0.44
CYP3A4 P08684 3/20 0.43
TSHR P16473 2/20 0.43
TP53 P04637 2/20 0.43
MEN1 O00255 1/20 0.43
ALOX5 P09917 1/20 0.43
MAPT P10636 1/20 0.43
ALOX15 P16050 1/20 0.43
HTT P42858 1/20 0.43
KMT2A Q03164 1/20 0.43
TDP1 Q9NUW8 1/20 0.43
PTPN1 P18031 1/20 0.42
PTPN11 Q06124 1/20 0.42
HMGCR P04035 1/20 0.41
AURKA O14965 1/20 0.37
RECQL P46063 1/20 0.37
ADRA2A P08913 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6676642 0.88 TYR (0.61) TYRESR1ESR2CYP3A4TSHR
SCHEMBL8022916 0.85 HSD17B3 (0.43) TYRESR1ESR2HSD17B3CYP3A4
SCHEMBL9386903 0.81 HTR2C (0.46) TYRESR1ESR2CYP3A4TSHR
SCHEMBL10825810 0.80 TYR (0.55) TYRESR1ESR2HSD17B3CYP3A4
SCHEMBL31613067 0.80 TYR (0.55) TYRESR1ESR2HSD17B3CYP3A4
SCHEMBL5931864 0.78 ESR1 (0.58) TYRESR1ESR2HSD17B3CYP3A4
SCHEMBL30014025 0.78 ESR1 (0.55) TYRESR1ESR2HSD17B3CYP3A4
SCHEMBL70464 0.78 ESR1 (0.55) TYRESR1ESR2HSD17B3CYP3A4
SCHEMBL9100129 0.77 CNR1 (0.45) ALOX5HMGCRCNR1CNR2
SCHEMBL1069010 0.77 TAAR1 (0.41) TSHRMEN1MAPTHTTKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050112693-A1 Diketodiazacyclic compounds, diazacyclic compounds and combinatorial libraries thereof NEFZI ADEL (US) 2005-05-26 US claimed
US-20030120066-A1 Synthetic peptides NEFZI ADEL (US) 2003-06-26 US claimed
US-6809202-B2 SYNTHETIC PEPTIDES TORREY PINES INSTITUTE FOR MOLECULAR STUDIES 2004-10-26 US disclosed
US-20030120066-A1 Synthetic peptides NEFZI ADEL (US) 2003-06-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050112693-A1 Diketodiazacyclic compounds, diazacyclic compounds and combinatorial libraries thereof DHPS, DCK, DAZAP1 TYR 4244/4885ESR1 4384/4885ESR2 4180/4885
US-20030120066-A1 Synthetic peptides VIP, NGLY1, GRPR TYR 4160/4885ESR1 4195/4885ESR2 3313/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.